Skip to content

ORASURE TECHNOLOGIES INC (OSUR) — insider trading

Health Care · NASDAQ

ORASURE TECHNOLOGIES INC (OSUR) has 16 reported SEC Form 4 insider transactions in our data, including 3 open-market purchases among the most recent 16 (latest 2026-09-29).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-09-29 Boyd Steven Kyle Director Grant / award / vesting 4,797 $3.88 $18.6K Form 4
2026-09-06 Kenny John P. Director Shares withheld for taxes / exercise cost 5,116 $3.43 $17.5K Form 4
2026-06-26 Boyd Steven Kyle Director Grant / award / vesting 3,666 $4.43 $16.2K Form 4
2026-06-03 Boyd Steven Kyle Director Grant / award / vesting 46,106 — $0 Form 4
2026-06-03 Bertrand John D. Director Grant / award / vesting 46,106 — $0 Form 4
2026-06-03 Kenny John P. Director Grant / award / vesting 46,106 — $0 Form 4
2026-06-03 Marmora Lelio Director Grant / award / vesting 46,106 — $0 Form 4
2026-06-03 Gagliano Nancy J Director Grant / award / vesting 46,106 — $0 Form 4
2026-06-03 McMahon Robert W. Director Grant / award / vesting 46,106 — $0 Form 4
2026-05-14 Boyd Steven Kyle Director Open-market purchase 25,000 $2.99 $74.8K Form 4
2026-05-13 Gagliano Nancy J Director Shares withheld for taxes / exercise cost 21,305 $3.02 $64.3K Form 4
2026-05-13 McMahon Robert W. Director Shares withheld for taxes / exercise cost 22,888 $3.02 $69.1K Form 4
2026-05-13 Marmora Lelio Director Shares withheld for taxes / exercise cost 28,406 $3.02 $85.8K Form 4
2026-05-13 Boyd Steven Kyle Director Open-market purchase 25,000 $3.02 $75.5K Form 4
2026-05-12 Bertrand John D. Director Grant / award / vesting 33,661 — $0 Form 4
2026-05-12 Boyd Steven Kyle Director Open-market purchase 25,000 $2.98 $74.5K Form 4

Ask the chat about OSUR's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: ORASURE TECHNOLOGIES INC (OSUR).

Last updated 2026-09-29 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.